Skip to main content
Toggle navigation
Login
Search
Home
Scientific Program
Back
View
Attendees
5
Favorite
Like
Facebook
Tweet
Print
Session: Cellular & Stem Cell Therapeutics
Protecting Transplanted Cells from Immune Rejection Is the Key to Unlocking the Potential of Regenerative Medicine
Thursday, June 20, 2024
1:00 PM – 1:25 PM
PT
Location: Salon 7
Speaker(s)
Sonja Schrepfer, MD, PhD
SVP, Head of Hypoimmune Platform
Sana Biotechnology
Disclosure(s):
Sonja Schrepfer, MD, PhD
: No relevant disclosure to display
Learning Objectives:
Upon completion, participant will be able to define adaptive versus innate immunity.
Upon completion, participant will be able to describe the allogeneic barrier in stem cell transplantation.
Upon completion, participant will be able to describe a strategy to overcome the alogeneic barrier in stem cell transplantation.
